Registry will have a single, up-to-date, centralized repository of all drugs across drug systems
Registry will have a single, up-to-date, centralized repository of all drugs across drug systems
The National Health Authority (NHA) has issued a consultation paper on the drug registry. Envisioned under the ambitious Ayushman Bharat Digital Mission (ABDM), the registry aims to be a single, up-to-date, centralized repository of all medicines across all systems of medicine, which are approved and available in the Indian market. The Health Ministry issued a release on Friday.
The drug registry application is proposed to be designed using open-source technologies and would be interoperable. The Ministry noted that the consultation paper focused only on the Registry within the National Digital Health Ecosystem and provides the NHA’s current vision on the functionality of the proposed Registry, its creation process and the potential benefits to various ecosystem stakeholders.
Comments requested
Each section has specific open questions where feedback from stakeholders is sought. Comments are invited from the public to ensure that the Registry is designed and developed in a collaborative and consultative manner.
RS Sharma, Chief Executive Officer, National Health Authority said: “Through the Drug Registry, ABDM aims to provide a standardized, comprehensively verified data on all approved drugs marketed in the country which will enable a more efficient regulatory process . “
NHA is leading the implementation of ABDM in coordination with various Ministries/Departments of Government of India, State Governments and Private Sector/Civil Society Organizations. It aims to bridge the existing gap between various stakeholders of the healthcare ecosystem through digital highways.